VERACYTE, INC. Finite-Lived Intangible Assets, Accumulated Amortization
VERACYTE, INC. (VCYT) had Finite-Lived Intangible Assets, Accumulated Amortization of $70.22 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-07-31
- 2026-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $70.22M.
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $67.06M.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $63.77M.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $60.44M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2026-06-30 | $70.22M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $67.06M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $63.77M 10-Q · filed 2026-07-31 |
| 2025-09-30 | $60.44M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $57.11M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $53.83M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $50.62M 10-K · filed 2026-02-26 |
| 2024-09-30 | $56.04M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $52.01M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $48.26M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $44.70M 10-K · filed 2025-02-28 |
| 2023-09-30 | $51.17M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $58.52M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $53.21M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $47.71M 10-K · filed 2024-02-29 |
| 2022-09-30 | $41.73M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $36.91M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $31.83M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $26.41M 10-K · filed 2023-03-01 |
| 2021-09-30 | $20.98M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $16.02M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $12.30M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $10.50M 10-K · filed 2022-02-28 |
| 2019-12-31 | $5.40M 10-K · filed 2021-02-22 |
| 2018-12-31 | $4.00M 10-K · filed 2020-02-25 |
| 2017-12-31 | $3.00M 10-K · filed 2019-02-25 |
| 2016-12-31 | $1.90M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |